[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Nifedipine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Nifedipine.]
[J01GA01, streptomycin, Nifedipine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA27, fingolimod, Nifedipine may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Nifedipine.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01CG01, sulbactam, Nifedipine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, Nifedipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Nifedipine.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Nifedipine.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Nifedipine.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Azapropazone.]
[N06DA01, tacrine, The metabolism of Nifedipine can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Nifedipine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Nifedipine.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Nifedipine.]
[B01AE07, dabigatran etexilate, Nifedipine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Tetrabenazine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Nifedipine.]
[A04AD10, dronabinol, The metabolism of Nifedipine can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nifedipine.]
[L04AX02, thalidomide, The metabolism of Nifedipine can be increased when combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Nifedipine.]
[P02CA02, thiabendazole, The metabolism of Nifedipine can be decreased when combined with Thiabendazole.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Nifedipine.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Nifedipine.]
[N05AB08, thioproperazine, The risk or severity of hypotension can be increased when Thioproperazine is combined with Nifedipine.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Nifedipine.]
[C01BB04, aprindine, Nifedipine may increase the arrhythmogenic activities of Aprindine.]
[G04BE06, moxisylyte, Nifedipine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Nifedipine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Nifedipine can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Timolol.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S01AA12, tobramycin, Nifedipine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Tolazamide.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Tolazoline is combined with Nifedipine.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Nifedipine.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Nifedipine.]
[N06AF04, tranylcypromine, The metabolism of Nifedipine can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Nifedipine.]
[L01XF01, tretinoin, The metabolism of Nifedipine can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Nifedipine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Nifedipine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of hypotension can be increased when Trifluoperazine is combined with Nifedipine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Nifedipine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Nifedipine may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, Nifedipine may increase the arrhythmogenic activities of Metipranolol.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nifedipine.]
[N03AC02, trimethadione, Trimethadione may increase the arrhythmogenic activities of Nifedipine.]
[C02BA01, trimethaphan, Nifedipine may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Nifedipine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Nifedipine.]
[R06AC04, tripelennamine, The metabolism of Nifedipine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Nifedipine.]
[J01FA08, troleandomycin, The metabolism of Nifedipine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Nifedipine can be decreased when combined with Vilazodone.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Nifedipine is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, Nifedipine may increase the neuromuscular blocking activities of Tubocurarine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Nifedipine.]
[L01FX04, ipilimumab, Nifedipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Vandetanib.]
[R02AA14, oxyquinoline, Nifedipine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The serum concentration of Nifedipine can be increased when it is combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Nifedipine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Nifedipine can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Nifedipine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Nifedipine.]
[S01AA28, vancomycin, Nifedipine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Nifedipine.]
[B01AF01, rivaroxaban, Nifedipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nifedipine.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Nifedipine.]
[C08DA01, verapamil, Verapamil may increase the arrhythmogenic activities of Nifedipine.]
[N06AX09, viloxazine, The metabolism of Nifedipine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, Vinblastine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C04AX07, vincamine, Nifedipine may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Nifedipine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[B01AA03, warfarin, The metabolism of Warfarin can be increased when combined with Nifedipine.]
[S01AA13, fusidic acid, The metabolism of Nifedipine can be decreased when combined with Fusidic acid.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The metabolism of Nifedipine can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Nifedipine can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Nifedipine can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M05BA05, tiludronic acid, Nifedipine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Nifedipine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Nifedipine.]
[A02BC04, rabeprazole, Nifedipine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Nifedipine.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Nifedipine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Nifedipine.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Nifedipine.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Nifedipine.]
[J01DH04, doripenem, Nifedipine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The metabolism of Nifedipine can be decreased when combined with Peginterferon alfa-2a.]
[J02AC03, voriconazole, The serum concentration of Nifedipine can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, Nifedipine may increase the neuromuscular blocking activities of Atracurium.]
[S01FA01, atropine, Atropine may increase the arrhythmogenic activities of Nifedipine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Nifedipine.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Nifedipine.]
[H02AB11, prednylidene, The metabolism of Nifedipine can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Nifedipine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L04AX01, azathioprine, The metabolism of Nifedipine can be decreased when combined with Azathioprine.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Nifedipine.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A08AA11, lorcaserin, The metabolism of Nifedipine can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Nifedipine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Nifedipine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Nifedipine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Nifedipine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nifedipine.]
[L04AA31, teriflunomide, The serum concentration of Nifedipine can be decreased when it is combined with Teriflunomide.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Nifedipine.]
[L01EX05, regorafenib, Nifedipine may increase the bradycardic activities of Regorafenib.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Nifedipine.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may increase the arrhythmogenic activities of Nifedipine.]
[D02BA02, octinoxate, Nifedipine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Nifedipine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Nifedipine.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Nifedipine.]
[C08CA13, lercanidipine, Lercanidipine may increase the arrhythmogenic activities of Nifedipine.]
[N06DA02, donepezil, Donepezil may increase the bradycardic activities of Nifedipine.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Nifedipine.]
[L04AA29, tofacitinib, Nifedipine may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Nifedipine.]
[G04BD10, darifenacin, The metabolism of Nifedipine can be decreased when combined with Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Nifedipine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Nifedipine.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Sildenafil is combined with Nifedipine.]
[V08CA11, gadofosveset, Nifedipine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Nifedipine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Nifedipine.]
[A16AX08, teduglutide, Nifedipine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Bedaquiline.]
[C04AX11, bencyclane, Nifedipine may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Nifedipine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Nifedipine.]
[G03XC05, ospemifene, The metabolism of Nifedipine can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Gemifloxacin.]
[M04AB03, benzbromarone, Nifedipine may decrease the excretion rate of Benzbromarone which could result in a higher serum level.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Nifedipine.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Nifedipine.]
[A06AX06, tegaserod, The metabolism of Nifedipine can be decreased when combined with Tegaserod.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Nifedipine can be decreased when combined with Benzocaine.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Pramlintide.]
[L03AA12, ancestim, Nifedipine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Nifedipine can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Nifedipine can be decreased when combined with Everolimus.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Nifedipine.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nifedipine.]
[L01EC02, dabrafenib, The serum concentration of Nifedipine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Benzydamine.]
[L01EE01, trametinib, Nifedipine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Nifedipine.]
[V09AX05, florbetapir F-18, Nifedipine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Nifedipine.]
[C08EA02, bepridil, Nifedipine may increase the arrhythmogenic activities of Bepridil.]
[C02KX05, riociguat, The risk or severity of adverse effects can be increased when Nifedipine is combined with Riociguat.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Lixisenatide.]
[A05AA03, cholic acid, Nifedipine may decrease the excretion rate of Cholic Acid which could result in a higher serum level.]
[C02KX04, macitentan, Nifedipine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Nifedipine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Nifedipine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Nifedipine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Nifedipine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Nifedipine.]
[A16AA07, metreleptin, The metabolism of Nifedipine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Nifedipine can be increased when combined with Apremilast.]
[L02BG02, formestane, Nifedipine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Nifedipine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Betaxolol.]
[V03AB34, fomepizole, The metabolism of Nifedipine can be decreased when combined with Fomepizole.]
[C02CC01, bethanidine, Nifedipine may increase the hypotensive activities of Bethanidine.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Nifedipine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, Nifedipine may increase the bradycardic activities of Ceritinib.]
[A03BA03, hyoscyamine, Hyoscyamine may increase the arrhythmogenic activities of Nifedipine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be increased when combined with Nifedipine.]
[L01XH04, belinostat, The metabolism of Nifedipine can be increased when combined with Belinostat.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Nifedipine.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A16AX10, eliglustat, The metabolism of Nifedipine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Nifedipine can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of hypotension can be increased when Acepromazine is combined with Nifedipine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Nifedipine.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Dulaglutide.]
[N04AA02, biperiden, The metabolism of Nifedipine can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Nifedipine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Nifedipine.]
[S03AA06, gentamicin, Nifedipine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Nifedipine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Nifedipine.]
[B01AF03, edoxaban, Nifedipine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Nifedipine can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Nifedipine can be increased when combined with Secukinumab.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Nifedipine can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Nifedipine.]
[N02BE01, acetaminophen, Nifedipine may increase the hepatotoxic activities of Acetaminophen.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01EB17, ivabradine, Nifedipine may increase the bradycardic activities of Ivabradine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Nifedipine can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The risk or severity of hypotension can be increased when Brexpiprazole is combined with Nifedipine.]
[A04AD14, rolapitant, The metabolism of Nifedipine can be decreased when combined with Rolapitant.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Nifedipine.]
[A10BF01, acarbose, Nifedipine may decrease the hypoglycemic activities of Acarbose.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Nifedipine can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Nifedipine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Nifedipine.]
[J02AC05, isavuconazole, The metabolism of Nifedipine can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Nifedipine can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Nifedipine.]
[L01XG03, ixazomib, Nifedipine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Nifedipine may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Acetohexamide.]
[G04CA01, alfuzosin, The risk or severity of hypotension can be increased when Alfuzosin is combined with Nifedipine.]
[M04AB05, lesinurad, Nifedipine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Nifedipine.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Alminoprofen.]
[N03AX23, brivaracetam, Nifedipine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Nifedipine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Nifedipine.]
[N04BC01, bromocriptine, The risk or severity of hypotension can be increased when Bromocriptine is combined with Nifedipine.]
[A02AD05, aluminum magnesium silicate, Nifedipine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Nifedipine.]
[C08CA01, amlodipine, Amlodipine may increase the arrhythmogenic activities of Nifedipine.]
[A05AA04, obeticholic acid, The metabolism of Nifedipine can be decreased when combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nifedipine.]
[C07AA19, bupranolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Nifedipine can be decreased when combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Nifedipine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, Rivastigmine may increase the bradycardic activities of Nifedipine.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Artemether.]
[M02AA03, clofezone, Nifedipine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Nifedipine.]
[S01GX07, azelastine, The metabolism of Nifedipine can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Nifedipine can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Nifedipine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Nifedipine.]
[L01EF02, ribociclib, The metabolism of Nifedipine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Nifedipine.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Nifedipine.]
[A06AH05, naldemedine, Nifedipine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Nifedipine.]
[N06BC01, caffeine, The metabolism of Nifedipine can be decreased when combined with Caffeine.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Nifedipine.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Benfluorex.]
[P01CA02, benznidazole, Nifedipine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[G04BA03, calcium chloride, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium chloride.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Nifedipine.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Nifedipine can be decreased when combined with Tipranavir.]
[D11AX03, calcium gluconate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium gluconate.]
[N07XX13, valbenazine, Nifedipine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Nifedipine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Nifedipine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Nifedipine.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nifedipine.]
[D01AC10, bifonazole, The therapeutic efficacy of Bifonazole can be increased when used in combination with Nifedipine.]
[P03AC02, bioallethrin, Nifedipine may increase the arrhythmogenic activities of Bioallethrin.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Nifedipine.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Nifedipine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Nifedipine.]
[C07AB07, bisoprolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bisoprolol.]
[J05AG03, efavirenz, The serum concentration of Nifedipine can be decreased when it is combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bopindolol.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Nifedipine is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Nifedipine may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Nifedipine can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Nifedipine.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Semaglutide.]
[N01BX04, capsaicin, The metabolism of Nifedipine can be increased when combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nifedipine.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Nifedipine is combined with Captopril.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Macimorelin.]
[L02BB05, apalutamide, The metabolism of Nifedipine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Nifedipine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Nifedipine.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Nifedipine.]
[L03AB06, interferon alfa-n1, The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Nifedipine.]
[N03AX24, cannabidiol, The metabolism of Nifedipine can be decreased when combined with Cannabidiol.]
[L04AA37, baricitinib, Nifedipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Encorafenib.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Nifedipine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01GB14, plazomicin, Nifedipine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Nifedipine.]
[L01XX62, ivosidenib, The metabolism of Nifedipine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Nifedipine.]
[A16AX14, migalastat, Nifedipine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Nifedipine can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Nifedipine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Nifedipine.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Nifedipine.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Carbutamide.]
[D08AE05, chloroxylenol, Nifedipine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Lornoxicam.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Nifedipine.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Nifedipine.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Nifedipine.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Nifedipine.]
[L04AA39, emapalumab, The metabolism of Nifedipine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Nifedipine can be decreased when combined with Carmustine.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Amifampridine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nifedipine.]
[C01BG07, cifenline, Nifedipine may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Nifedipine is combined with Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Nifedipine.]
[S01ED05, carteolol, Nifedipine may increase the arrhythmogenic activities of Carteolol.]
[P02BX04, triclabendazole, The metabolism of Nifedipine can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The metabolism of Nifedipine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Nifedipine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, The metabolism of Nifedipine can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Nifedipine can be increased when combined with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Nifedipine.]
[V03AE07, calcium acetate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Nifedipine can be increased when combined with Etanercept.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Nifedipine.]
[H02AB17, cortivazol, The metabolism of Nifedipine can be increased when combined with Cortivazol.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C03BX03, cicletanine, Nifedipine may increase the arrhythmogenic activities of Cicletanine.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Nifedipine can be decreased when combined with Cyclobenzaprine.]
[L01EJ02, fedratinib, The metabolism of Nifedipine can be decreased when combined with Fedratinib.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Nifedipine can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Nifedipine.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Nifedipine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Nifedipine.]
[A10AE03, insulin, regular, pork, The metabolism of Nifedipine can be increased when combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Nifedipine.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Nifedipine.]
[N02CC08, lasmiditan, Lasmiditan may increase the bradycardic activities of Nifedipine.]
[N03AX25, cenobamate, The serum concentration of Nifedipine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Nifedipine can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Nifedipine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Nifedipine.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, Nifedipine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Nifedipine.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Nifedipine.]
[M01AX21, diacetylrhein, The metabolism of Nifedipine can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Nifedipine.]
[S01AE06, gatifloxacin, The metabolism of Nifedipine can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Nifedipine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Nifedipine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Nifedipine can be decreased when combined with Frovatriptan.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Nifedipine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Nifedipine.]
[R02AA03, dichlorobenzyl alcohol, Nifedipine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Nifedipine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Nifedipine.]
[N02CC06, eletriptan, The metabolism of Nifedipine can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Nifedipine can be decreased when combined with Rofecoxib.]
[C08CA16, clevidipine, Nifedipine may increase the arrhythmogenic activities of Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Nifedipine can be increased when it is combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Nifedipine can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Nifedipine.]
[C02AA06, methoserpidine, Nifedipine may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Nifedipine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Nifedipine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Nifedipine is combined with Opicapone.]
[D07XB03, fluprednidene, The metabolism of Nifedipine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Nifedipine can be decreased when combined with Trospium.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Droxicam.]
[V08CA05, mangafodipir, Nifedipine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Nifedipine.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Nifedipine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Nifedipine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Nifedipine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nifedipine.]
[P01BB01, proguanil, The metabolism of Nifedipine can be decreased when combined with Proguanil.]
[L01FX15, belantamab mafodotin, Nifedipine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[L04AC19, satralizumab, The serum concentration of Nifedipine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Nifedipine.]
[P01BA01, chloroquine, The metabolism of Nifedipine can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Nifedipine.]
[N05AA01, chlorpromazine, The metabolism of Nifedipine can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Chlorpropamide.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nifedipine.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Nifedipine can be decreased when combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Nifedipine can be decreased when combined with Cholecalciferol.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Ethenzamide.]
[N02BA03, choline salicylate, Nifedipine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, Nifedipine may increase the arrhythmogenic activities of Vinpocetine.]
[M01AB08, etodolac, The risk or severity of hyperkalemia can be increased when Etodolac is combined with Nifedipine.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Nifedipine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Nifedipine can be decreased when combined with Lonafarnib.]
[M09AA01, hydroquinine, Nifedipine may increase the arrhythmogenic activities of Hydroquinine.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nifedipine.]
[M01AX25, chondroitin sulfates, Nifedipine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Nifedipine can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Nifedipine is combined with Vericiguat.]
[V03AF12, trilaciclib, The metabolism of Nifedipine can be increased when combined with Trilaciclib.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Felbamate is combined with Nifedipine.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Fenbufen.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Nifedipine.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Fenoldopam is combined with Nifedipine.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Nifedipine.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01MB07, flumequine, The metabolism of Nifedipine can be decreased when combined with Flumequine.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S01JA01, fluorescein, Fluorescein may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N02BG07, flupirtine, Nifedipine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Nifedipine can be decreased when combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Nifedipine.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Nifedipine.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Nifedipine can be increased when it is combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Nifedipine may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the arrhythmogenic activities of Nifedipine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Nifedipine.]
[L01XX73, sotorasib, The serum concentration of Nifedipine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Nifedipine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Nifedipine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Nifedipine can be increased when combined with Somapacitan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Nifedipine is combined with Fexinidazole.]
[H01AC09, lonapegsomatropin, The metabolism of Nifedipine can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Mobocertinib.]
[V09AB03, ioflupane I-123, Nifedipine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Nifedipine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Nifedipine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Clemastine.]
[M01AG01, mefenamic acid, The metabolism of Nifedipine can be decreased when combined with Mefenamic acid.]
[A10BB12, glimepiride, Glimepiride may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Gliquidone.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium glubionate anhydrous.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Nifedipine.]
[N06AX25, St. John's wort extract, The serum concentration of Nifedipine can be decreased when it is combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Nifedipine can be decreased when combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, The metabolism of Nifedipine can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Nifedipine can be decreased when combined with Clofibrate.]
[N01BB10, levobupivacaine, The metabolism of Nifedipine can be decreased when combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Nifedipine can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Nifedipine.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Nifedipine.]
[S01EA04, clonidine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nifedipine.]
[C01EB24, mavacamten, The serum concentration of Nifedipine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Nifedipine.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Nifedipine.]
[A05BA08, glycyrrhizic acid, Nifedipine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nifedipine.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Granisetron is combined with Nifedipine.]
[N05AH02, clozapine, The metabolism of Nifedipine can be decreased when combined with Clozapine.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Sotagliflozin.]
[J01GB12, arbekacin, Nifedipine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Nifedipine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Cocaine.]
[C02KB01, metyrosine, Nifedipine may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Nifedipine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Proquazone.]
[R05DA04, codeine, The metabolism of Nifedipine can be decreased when combined with Codeine.]
[M04AC01, colchicine, Nifedipine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Nifedipine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L04AA13, leflunomide, The serum concentration of Nifedipine can be decreased when it is combined with Leflunomide.]
[C01BA13, hydroquinidine, Nifedipine may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Nifedipine.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Nifedipine.]
[A04AA03, tropisetron, Nifedipine may increase the arrhythmogenic activities of Tropisetron.]
[A10BX03, nateglinide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Nifedipine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Nifedipine.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Nifedipine.]
[J05AB14, valganciclovir, Nifedipine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Nifedipine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Nifedipine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Nifedipine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Nifedipine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Nifedipine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Nifedipine.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Nifedipine.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Nifedipine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Bemiparin.]
[S01AD03, acyclovir, The metabolism of Nifedipine can be decreased when combined with Acyclovir.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Nifedipine.]
[N05BA10, ketazolam, Nifedipine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Nifedipine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Nifedipine can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Nifedipine may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Nifedipine.]
[N03AX09, lamotrigine, Lamotrigine may increase the arrhythmogenic activities of Nifedipine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Nifedipine.]
[S01BA03, cortisone, The metabolism of Nifedipine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Nifedipine.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Lonazolac.]
[R06AX13, loratadine, Loratadine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Loxoprofen.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Nifedipine.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Nifedipine.]
[A06AD01, magnesium carbonate, The risk or severity of hypotension can be increased when Magnesium carbonate is combined with Nifedipine.]
[C08CA11, manidipine, Nifedipine may increase the arrhythmogenic activities of Manidipine.]
[C07AA14, mepindolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Nifedipine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Nifedipine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01EB10, adenosine, Adenosine may increase the arrhythmogenic activities of Nifedipine.]
[C04AX01, cyclandelate, Nifedipine may increase the arrhythmogenic activities of Cyclandelate.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Nifedipine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Nifedipine may increase the arrhythmogenic activities of Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Miglitol.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Nifedipine.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Nifedipine.]
[S01XA18, cyclosporine, The metabolism of Nifedipine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Nifedipine.]
[N06BA07, modafinil, The metabolism of Nifedipine can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Nifedipine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Nifedipine.]
[C10AA07, rosuvastatin, Rosuvastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Nifedipine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Moxonidine.]
[J05AF10, entecavir, The metabolism of Nifedipine can be decreased when combined with Entecavir.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Nifedipine.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Nifedipine.]
[L01AX04, dacarbazine, The metabolism of Nifedipine can be decreased when combined with Dacarbazine.]
[G03XA01, danazol, The metabolism of Nifedipine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Nifedipine.]
[J04BA02, dapsone, The metabolism of Nifedipine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, Daunorubicin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Nifedipine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Nifedipine.]
[M01AX01, nabumetone, The metabolism of Nifedipine can be decreased when combined with Nabumetone.]
[N07BB05, nalmefene, Nifedipine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Nifedipine.]
[C07AB12, nebivolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Nifedipine can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Nifedipine.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Nifedipine.]
[M03AC11, cisatracurium, Nifedipine may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AB10, escitalopram, The serum concentration of Nifedipine can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Nifedipine.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Nifedipine can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, Deslanoside may increase the arrhythmogenic activities of Nifedipine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V04CH02, indigo carmine, Nifedipine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Nifedipine is combined with Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Nifedipine.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Nifedipine.]
[N03AF02, oxcarbazepine, The metabolism of Nifedipine can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Nifedipine can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Nifedipine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Nifedipine.]
[L04AB04, adalimumab, The metabolism of Nifedipine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Nifedipine can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Nifedipine can be decreased when combined with Dextromethorphan.]
[N06AB05, paroxetine, The metabolism of Nifedipine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nifedipine.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Nifedipine.]
[P03AC04, permethrin, Nifedipine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Nifedipine is combined with Diazoxide.]
[R05DA08, pholcodine, Nifedipine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Nifedipine.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C02DG01, pinacidil, Nifedipine may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, Nifedipine may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The serum concentration of Nifedipine can be decreased when it is combined with Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Nifedipine is combined with Pipamperone.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Nifedipine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Nifedipine.]
[D07XC04, diflucortolone, The metabolism of Nifedipine can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Nifedipine.]
[C01AA04, digitoxin, Nifedipine may increase the arrhythmogenic activities of Digitoxin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Nifedipine.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Nifedipine.]
[C10AX09, ezetimibe, Ezetimibe may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C04AE04, dihydroergocristine, Nifedipine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[N02CA01, dihydroergotamine, The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Nifedipine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Nifedipine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Nifedipine.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Nifedipine.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C08DB01, diltiazem, The serum concentration of Nifedipine can be increased when it is combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Nifedipine.]
[V03AB09, dimercaprol, Nifedipine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Nifedipine can be decreased when combined with Dimethyl sulfoxide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Nifedipine.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Proglumetacin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Nifedipine.]
[R06AA02, diphenhydramine, The metabolism of Nifedipine can be decreased when combined with Diphenhydramine.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Quinapril is combined with Nifedipine.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Nifedipine.]
[A03FA02, cisapride, The serum concentration of Nifedipine can be increased when it is combined with Cisapride.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Nifedipine.]
[S01XA23, sirolimus, Nifedipine may increase the immunosuppressive activities of Sirolimus.]
[N05AL04, remoxipride, The metabolism of Nifedipine can be decreased when combined with Remoxipride.]
[S01AX06, resorcinol, Nifedipine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may increase the arrhythmogenic activities of Nifedipine.]
[P03AA04, disulfiram, Disulfiram may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S02AA12, rifamycin SV, The metabolism of Nifedipine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Nifedipine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The metabolism of Nifedipine can be decreased when combined with Riluzole.]
[N05AX08, risperidone, Nifedipine may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Nifedipine.]
[N01BB09, ropivacaine, The metabolism of Nifedipine can be decreased when combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Nifedipine can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Nifedipine.]
[A04AD12, aprepitant, The metabolism of Nifedipine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Nifedipine can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Nifedipine.]
[S01BC05, ketorolac, The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Nifedipine.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Nifedipine.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Nifedipine.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Nifedipine.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Nifedipine can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The risk or severity of hypotension can be increased when Doxepin is combined with Nifedipine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Nifedipine.]
[L01DB01, doxorubicin, Doxorubicin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Nifedipine.]
[N06AB06, sertraline, The metabolism of Nifedipine can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of hypotension can be increased when Sevoflurane is combined with Nifedipine.]
[N05AD08, droperidol, The risk or severity of hypotension can be increased when Droperidol is combined with Nifedipine.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C10AA01, simvastatin, Simvastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V03AG05, sodium phosphate, Sodium phosphate, monobasic may increase the hyperkalemic activities of Nifedipine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Nifedipine.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Sultopride.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Talinolol.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Temafloxacin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Nifedipine.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Terazosin is combined with Nifedipine.]
[D01BA02, terbinafine, The metabolism of Nifedipine can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, Nifedipine may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Tertatolol.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Nifedipine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Nifedipine.]
[M01AG02, tolfenamic acid, Nifedipine may increase the bradycardic activities of Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Nifedipine.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Nifedipine.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Toremifene.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Nifedipine.]
[N05CC01, chloral hydrate, Nifedipine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Nifedipine.]
[C02CA06, urapidil, The risk or severity of hypotension can be increased when Urapidil is combined with Nifedipine.]
[J01MA04, enoxacin, The metabolism of Nifedipine can be decreased when combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Nifedipine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nifedipine.]
[N06AX16, venlafaxine, The metabolism of Nifedipine can be decreased when combined with Venlafaxine.]
[S01GA03, xylometazoline, Nifedipine may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Nifedipine may increase the arrhythmogenic activities of Barnidipine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Zofenopril.]
[N05CF02, zolpidem, The metabolism of Nifedipine can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the arrhythmogenic activities of Nifedipine.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin glulisine.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Nifedipine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Nifedipine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Iloprost is combined with Nifedipine.]
[C01BG01, moricizine, Moricizine may increase the arrhythmogenic activities of Nifedipine.]
[N02CA02, ergotamine, The metabolism of Nifedipine can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, Valproic acid may increase the hypotensive activities of Nifedipine.]
[C01DA13, erythrityl tetranitrate, Nifedipine may increase the vasodilatory activities of Erythrityl tetranitrate.]
[L03AX05, pidotimod, Nifedipine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, Erythromycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05CD04, estazolam, Nifedipine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Nifedipine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Nifedipine can be decreased when combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Nifedipine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Nifedipine can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Nifedipine can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Nifedipine can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, Ethinylestradiol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Nifedipine.]
[N03AD01, ethosuximide, Ethosuximide may increase the arrhythmogenic activities of Nifedipine.]
[M01AC06, meloxicam, The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Nifedipine.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Nifedipine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Nifedipine.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Nifedipine.]
[C01BA05, ajmaline, Nifedipine may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, Nifedipine may increase the immunosuppressive activities of Tacrolimus.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Nifedipine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Nifedipine.]
[R06AX12, terfenadine, The metabolism of Nifedipine can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Nifedipine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Nifedipine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Nifedipine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, Tocainide may increase the arrhythmogenic activities of Nifedipine.]
[C01BC08, encainide, Nifedipine may increase the arrhythmogenic activities of Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nifedipine.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Nifedipine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[D11AX24, deoxycholic acid, Deoxycholic acid may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Nifedipine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Nifedipine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Nifedipine can be increased when combined with Albendazole.]
[C08CA02, felodipine, Felodipine may increase the arrhythmogenic activities of Nifedipine.]
[C08EA01, fendiline, Nifedipine may increase the arrhythmogenic activities of Fendiline.]
[N03AX26, fenfluramine, The metabolism of Nifedipine can be decreased when combined with Fenfluramine.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Nifedipine.]
[N02AB03, fentanyl, Fentanyl may increase the bradycardic activities of Nifedipine.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Nifedipine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nifedipine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[G04BD02, flavoxate, Nifedipine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, Nifedipine may increase the arrhythmogenic activities of Flecainide.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Floctafenine.]
[J01CF05, floxacillin, Flucloxacillin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Nifedipine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[V03AB25, flumazenil, Nifedipine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Nifedipine may increase the arrhythmogenic activities of Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Nifedipine.]
[D07AC08, fluocinonide, The metabolism of Nifedipine can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Nifedipine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Nifedipine.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Nifedipine.]
[N06AB03, fluoxetine, The serum concentration of Nifedipine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Flupentixol.]
[N05AB02, fluphenazine, The metabolism of Nifedipine can be decreased when combined with Fluphenazine.]
[N05CD01, flurazepam, The metabolism of Nifedipine can be decreased when combined with Flurazepam.]
[S01BC04, flurbiprofen, The risk or severity of hyperkalemia can be increased when Flurbiprofen is combined with Nifedipine.]
[N05AG01, fluspirilene, Nifedipine may increase the arrhythmogenic activities of Fluspirilene.]
[L02BB01, flutamide, The metabolism of Nifedipine can be decreased when combined with Flutamide.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Nifedipine.]
[M03AA01, alcuronium, Nifedipine may increase the neuromuscular blocking activities of Alcuronium.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Nifedipine.]
[J05AE10, darunavir, The serum concentration of Nifedipine can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Nifedipine.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Nifedipine.]
[M03AC02, gallamine, Nifedipine may increase the neuromuscular blocking activities of Gallamine.]
[C08DA02, gallopamil, Nifedipine may increase the arrhythmogenic activities of Gallopamil.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Nifedipine.]
[C10AB04, gemfibrozil, The metabolism of Nifedipine can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Nifedipine.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Nifedipine.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Nifedipine.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Liraglutide.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, Nifedipine may increase the arrhythmogenic activities of Methsuximide.]
[N01AH02, alfentanil, Alfentanil may increase the bradycardic activities of Nifedipine.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nifedipine.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Gliclazide.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The metabolism of Nifedipine can be decreased when combined with Dexmedetomidine.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Nifedipine.]
[C05AE01, nitroglycerin, Nifedipine may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, Dofetilide may increase the arrhythmogenic activities of Nifedipine.]
[C02CA04, doxazosin, The serum concentration of Doxazosin can be decreased when it is combined with Nifedipine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Nifedipine.]
[C07AB09, esmolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Esmolol.]
[M01CB04, aurothioglucose, Nifedipine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Nifedipine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Nifedipine.]
[S01EX01, guanethidine, Nifedipine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nifedipine.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Haloperidol.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Nifedipine.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Nifedipine.]
[N05AH04, quetiapine, The risk or severity of hypotension can be increased when Quetiapine is combined with Nifedipine.]
[N06BX13, idebenone, Nifedipine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Nifedipine can be decreased when combined with Irinotecan.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C09CA01, losartan, Losartan may increase the arrhythmogenic activities of Nifedipine.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Heparin is combined with Nifedipine.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Nifedipine.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Nifedipine.]
[G03DC01, allylestrenol, Nifedipine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Nifedipine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Nifedipine.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Nifedipine.]
[J05AG01, nevirapine, The metabolism of Nifedipine can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Nifedipine may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Nifedipine may increase the arrhythmogenic activities of Nimesulide.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Oxatomide.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Perindopril is combined with Nifedipine.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA01, hydrocortisone, The metabolism of Nifedipine can be increased when combined with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Nifedipine.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Nifedipine.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Nifedipine.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[G04BD06, propiverine, The risk or severity of hypotension can be increased when Propiverine is combined with Nifedipine.]
[P01BA02, hydroxychloroquine, The metabolism of Nifedipine can be decreased when combined with Hydroxychloroquine.]
[B05AA07, hetastarch, Nifedipine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Hydroxyzine.]
[C02AC06, rilmenidine, Nifedipine may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of hyperkalemia can be increased when Ibuprofen is combined with Nifedipine.]
[B05XA08, sodium acetate, Nifedipine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Nifedipine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Nifedipine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Nifedipine.]
[H01AC02, somatrem, The metabolism of Nifedipine can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Nifedipine.]
[N06AA02, imipramine, The metabolism of Nifedipine can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Nifedipine.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Terlipressin.]
[R01AD07, tixocortol, Nifedipine may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The metabolism of Nifedipine can be decreased when combined with Tizanidine.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Indoramin is combined with Nifedipine.]
[A11HA07, inositol, Nifedipine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The metabolism of Nifedipine can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Nifedipine can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Nifedipine.]
[S01XA28, varenicline, Nifedipine may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Sitagliptin.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Nifedipine can be decreased when combined with Ramelteon.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Nifedipine.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Vildagliptin.]
[C10AA06, cerivastatin, Cerivastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The metabolism of Nifedipine can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, Nifedipine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Nifedipine.]
[J05AB13, penciclovir, The metabolism of Nifedipine can be decreased when combined with Penciclovir.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Nifedipine.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Nifedipine is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Nifedipine.]
[N04BX02, entacapone, The metabolism of Nifedipine can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Nifedipine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Nifedipine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Nifedipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Nifedipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Isoxsuprine.]
[N06AX18, reboxetine, The metabolism of Nifedipine can be decreased when combined with Reboxetine.]
[S01AA24, kanamycin, Nifedipine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The metabolism of Nifedipine can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Nifedipine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Nifedipine may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Nifedipine may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Nifedipine may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The metabolism of Nifedipine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Nifedipine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The risk or severity of hypotension can be increased when Olanzapine is combined with Nifedipine.]
[M02AA10, ketoprofen, The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Nifedipine.]
[V03AC03, deferasirox, The serum concentration of Nifedipine can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Nifedipine can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Mizolastine.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Nifedipine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Nifedipine.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Nifedipine.]
[C02AA05, deserpidine, Nifedipine may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Nifedipine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Nifedipine.]
[N03AX18, lacosamide, Nifedipine may increase the bradycardic activities of Lacosamide.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A05AA02, ursodiol, Nifedipine may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.]
[G03AD01, levonorgestrel, The metabolism of Nifedipine can be decreased when combined with Levonorgestrel.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Nifedipine is combined with Levodopa.]
[C08EX01, lidoflazine, Nifedipine may increase the arrhythmogenic activities of Lidoflazine.]
[S01AA21, amikacin, Nifedipine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Nifedipine can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Nifedipine.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Nifedipine can be decreased when combined with Lisuride.]
[A07DA03, loperamide, Loperamide may increase the arrhythmogenic activities of Nifedipine.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium pangamate.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Nifedipine can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Nifedipine.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Nifedipine.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Nifedipine.]
[A12CC10, magnesium oxide, The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nifedipine.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the arrhythmogenic activities of Nifedipine.]
[L01BA05, pralatrexate, Nifedipine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Nifedipine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The metabolism of Nifedipine can be decreased when combined with Maprotiline.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Nifedipine.]
[R06AE05, meclizine, The metabolism of Nifedipine can be decreased when combined with Meclizine.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Nifedipine.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Nifedipine.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Nifedipine.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Nifedipine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Dalteparin.]
[N05CH01, melatonin, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Melatonin.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Nifedipine can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Nifedipine.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[G04BX16, tiopronin, Nifedipine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nifedipine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Paliperidone.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Metformin.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Nifedipine.]
[H01CB03, lanreotide, Nifedipine may increase the bradycardic activities of Lanreotide.]
[N07BC02, methadone, The risk or severity of QTc prolongation can be increased when Methadone is combined with Nifedipine.]
[N06BA03, methamphetamine, Nifedipine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Nifedipine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Nifedipine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Nifedipine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N02BG08, ziconotide, Nifedipine may increase the arrhythmogenic activities of Ziconotide.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The metabolism of Nifedipine can be decreased when combined with Methotrimeprazine.]
[D05BA02, methoxsalen, The metabolism of Nifedipine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Nifedipine can be decreased when combined with Methoxyflurane.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Nifedipine.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Methyldopa is combined with Nifedipine.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Nifedipine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Nifedipine.]
[G03EK01, methyltestosterone, Nifedipine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The metabolism of Nifedipine can be decreased when combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[P01AB01, metronidazole, The metabolism of Nifedipine can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Nifedipine can be decreased when combined with Metyrapone.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Nifedipine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Nifedipine.]
[S02AA13, miconazole, The metabolism of Nifedipine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Nifedipine.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Parnaparin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01CA17, midodrine, Midodrine may increase the bradycardic activities of Nifedipine.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Nifedipine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Nifedipine.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Nifedipine.]
[L01XX23, mitotane, The metabolism of Nifedipine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Nifedipine can be decreased when combined with Lisdexamfetamine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nifedipine.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nifedipine.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Nifedipine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Nifedipine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Nifedipine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Nifedipine.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Ammonium chloride.]
[L01EX03, pazopanib, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Pazopanib.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M03AC03, vecuronium, Nifedipine may increase the neuromuscular blocking activities of Vecuronium.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Nifedipine.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Nifedipine.]
[G04CA04, silodosin, The risk or severity of hypotension can be increased when Silodosin is combined with Nifedipine.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Nifedipine.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be increased when it is combined with Nifedipine.]
[L03AB08, interferon beta-1b, The metabolism of Nifedipine can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Nadolol.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Nifedipine is combined with Ropinirole.]
[J01CF06, nafcillin, The therapeutic efficacy of Nifedipine can be decreased when used in combination with Nafcillin.]
[V03AB15, naloxone, The metabolism of Nifedipine can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Nifedipine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Nifedipine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Nifedipine.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Nifedipine.]
[L02BG04, letrozole, The metabolism of Nifedipine can be decreased when combined with Letrozole.]
[S03AA01, neomycin, Nifedipine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Nifedipine.]
[A10BX02, repaglinide, Repaglinide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01CX08, levosimendan, Levosimendan may increase the arrhythmogenic activities of Nifedipine.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Iloperidone.]
[J02AA01, amphotericin B, Nifedipine may decrease the nephrotoxic activities of Amphotericin B.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[L03AX16, plerixafor, Nifedipine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Nifedipine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Nifedipine can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C01CE01, inamrinone, Nifedipine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Nifedipine can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Nifedipine.]
[C08CA04, nicardipine, Nicardipine may increase the arrhythmogenic activities of Nifedipine.]
[C04AE02, nicergoline, The risk or severity of hypotension can be increased when Nicergoline is combined with Nifedipine.]
[P02DA01, niclosamide, The metabolism of Nifedipine can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Nifedipine can be decreased when combined with Nicotine.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Nifedipine.]
[C01DA05, pentaerythritol tetranitrate, Nifedipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Niflumic acid.]
[V03AB22, amyl nitrite, Nifedipine may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the arrhythmogenic activities of Nifedipine.]
[C08CA07, nisoldipine, Nisoldipine may increase the arrhythmogenic activities of Nifedipine.]
[C08CA08, nitrendipine, Nitrendipine may increase the arrhythmogenic activities of Nifedipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nifedipine.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nifedipine.]
[C02DD01, nitroprusside, Nifedipine may increase the hypotensive activities of Nitroprusside.]
[G03DC02, norethindrone, The metabolism of Nifedipine can be decreased when combined with Norethisterone.]
[S01AE02, norfloxacin, The metabolism of Nifedipine can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, Bosentan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Nifedipine.]
[L03AB07, interferon beta-1a, The metabolism of Nifedipine can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, Nifedipine may increase the arrhythmogenic activities of Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Reviparin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nifedipine.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Nifedipine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Nifedipine can be increased when combined with Omeprazole.]
[N02AA02, opium, Nifedipine may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nifedipine.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Nifedipine.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Nifedipine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Nifedipine.]
[C07AA02, oxprenolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Nifedipine can be decreased when combined with Oxycodone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Nifedipine.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Oxyphenbutazone.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Nifedipine.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Asenapine.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Danaparoid.]
[M03AC01, pancuronium, Nifedipine may increase the neuromuscular blocking activities of Pancuronium.]
[J04AB30, capreomycin, Nifedipine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Nifedipine.]
[H02AB05, paramethasone, The metabolism of Nifedipine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Nifedipine.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01MA03, pefloxacin, The metabolism of Nifedipine can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, Nifedipine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Penbutolol.]
[N05AG03, penfluridol, Nifedipine may increase the arrhythmogenic activities of Penfluridol.]
[J01CE09, penicillin G procaine, Nifedipine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Nifedipine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Nifedipine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, The metabolism of Nifedipine can be decreased when combined with Pentoxifylline.]
[C08EX02, perhexiline, Perhexiline may increase the arrhythmogenic activities of Nifedipine.]
[N05AB03, perphenazine, The metabolism of Nifedipine can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Nifedipine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Nifedipine.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Phenformin.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Nifedipine.]
[N03AA02, phenobarbital, The metabolism of Nifedipine can be increased when combined with Phenobarbital.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Nifedipine.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Nifedipine.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Phentolamine is combined with Nifedipine.]
[M02AA01, phenylbutazone, The risk or severity of hyperkalemia can be increased when Phenylbutazone is combined with Nifedipine.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Nifedipine is combined with Phenylephrine.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Nifedipine.]
[L04AB06, golimumab, The metabolism of Nifedipine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Levofloxacin.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C08CX01, mibefradil, Nifedipine may increase the arrhythmogenic activities of Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Nifedipine can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Nifedipine.]
[C07AA03, pindolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Pindolol.]
[C10AA05, atorvastatin, Atorvastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Nifedipine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Nifedipine can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Nifedipine.]
[N06BX03, piracetam, Nifedipine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Eprosartan is combined with Nifedipine.]
[S01BC06, piroxicam, The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Nifedipine.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Grepafloxacin.]
[N02CX01, pizotyline, The risk or severity of hypotension can be increased when Pizotifen is combined with Nifedipine.]
[J05AG02, delavirdine, The metabolism of Nifedipine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The serum concentration of the active metabolites of Irbesartan can be increased when Irbesartan is used in combination with Nifedipine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Nifedipine.]
[A03AE01, alosetron, The metabolism of Nifedipine can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Nifedipine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Nifedipine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Saxagliptin.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Nifedipine.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Nifedipine.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin lispro.]
[C10AA08, pitavastatin, Nifedipine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Practolol.]
[C01BA08, prajmaline, Nifedipine may increase the arrhythmogenic activities of Prajmaline.]
[P02BA01, praziquantel, The metabolism of Nifedipine can be decreased when combined with Praziquantel.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Nifedipine.]
[H02AB07, prednisone, The metabolism of Nifedipine can be increased when combined with Prednisone.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Antazoline.]
[C01DX02, prenylamine, Nifedipine may increase the arrhythmogenic activities of Prenylamine.]
[P01BA03, primaquine, The metabolism of Nifedipine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Nifedipine can be increased when combined with Primidone.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Probucol.]
[C01BA02, procainamide, Procainamide may increase the arrhythmogenic activities of Nifedipine.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Nifedipine.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Nifedipine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Nifedipine.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AA03, promazine, The risk or severity of hypotension can be increased when Promazine is combined with Nifedipine.]
[R06AD02, promethazine, The metabolism of Nifedipine can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propafenone.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[N05AC01, periciazine, The risk or severity of hypotension can be increased when Periciazine is combined with Nifedipine.]
[N05CM06, propiomazine, The risk or severity of hypotension can be increased when Propiomazine is combined with Nifedipine.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of QTc prolongation can be increased when Propofol is combined with Nifedipine.]
[N02AC04, propoxyphene, The metabolism of Nifedipine can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propranolol.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Nifedipine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Nifedipine is combined with Epoprostenol.]
[R03DC03, montelukast, The metabolism of Nifedipine can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Nifedipine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Nifedipine.]
[N07XX07, dalfampridine, Nifedipine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Nifedipine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Nifedipine.]
[R06AC01, pyrilamine, The metabolism of Nifedipine can be decreased when combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Nifedipine can be decreased when combined with Quinacrine.]
[C01BA01, quinidine, Quinidine may increase the arrhythmogenic activities of Nifedipine.]
[P01BC01, quinine, The metabolism of Nifedipine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Nifedipine can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Nifedipine can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Nifedipine.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Nifedipine.]
[S01BC08, salicylic acid, The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Nifedipine.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Nifedipine.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Nifedipine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Nifedipine is combined with Obinutuzumab.]
[J01GB08, sisomicin, Nifedipine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Nifedipine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Nifedipine.]
[C07AA07, sotalol, The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Sotalol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Nifedipine.]
[C03DA01, spironolactone, Spironolactone may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
